Why do nsaids cause ulcers

Content on WhatAnswers is provided "as is" for informational purposes. While we strive for accuracy, we make no guarantees. Content is AI-assisted and should not be used as professional advice.

Last updated: April 8, 2026

Quick Answer: NSAIDs cause ulcers primarily by inhibiting cyclooxygenase (COX) enzymes, which reduces protective prostaglandins in the stomach lining. This leads to decreased mucus and bicarbonate secretion, increased acid production, and impaired blood flow, making the stomach vulnerable to damage. Studies show that about 15-30% of chronic NSAID users develop ulcers, with higher risks in older adults and those with prior ulcer history. The risk increases with higher doses and longer duration of use, particularly with non-selective NSAIDs like ibuprofen and naproxen.

Key Facts

NSAIDs inhibit COX-1 and COX-2 enzymes, reducing prostaglandin synthesis by up to 70-90% in the stomach
Chronic NSAID use increases ulcer risk by 3-5 times compared to non-users
Approximately 2-4% of NSAID users develop serious gastrointestinal complications annually
The first NSAID, aspirin, was synthesized in 1897 by Felix Hoffmann at Bayer
Selective COX-2 inhibitors (like celecoxib) reduce ulcer risk by 50-60% compared to traditional NSAIDs

Overview

Nonsteroidal anti-inflammatory drugs (NSAIDs) are among the most commonly used medications worldwide, with over 30 million people taking them daily. First developed in the late 19th century with aspirin's synthesis in 1897, NSAIDs have evolved to include numerous prescription and over-the-counter options like ibuprofen (introduced 1969), naproxen (1976), and diclofenac (1979). These medications provide effective pain relief and anti-inflammatory effects but carry significant gastrointestinal risks. The connection between NSAIDs and ulcers was systematically documented in the 1970s and 1980s, leading to FDA warnings and black box labels. Today, NSAID-induced ulcers account for approximately 30% of all peptic ulcer cases, representing a major public health concern given their widespread use for conditions ranging from arthritis to headaches.

How It Works

NSAIDs cause ulcers through multiple interconnected mechanisms centered on prostaglandin inhibition. These drugs work by blocking cyclooxygenase (COX) enzymes, particularly COX-1, which is constitutively expressed in the gastric mucosa. Normally, COX-1 converts arachidonic acid to prostaglandins like PGE2 and PGI2, which maintain gastric protection by stimulating mucus and bicarbonate secretion, maintaining mucosal blood flow, and promoting epithelial cell renewal. When NSAIDs inhibit COX-1 by 70-90%, prostaglandin levels drop dramatically, reducing mucus thickness by 40-60% and bicarbonate secretion by 50-70%. Simultaneously, NSAIDs allow increased acid production by parietal cells and cause direct topical damage to epithelial cells. The compromised mucosal barrier becomes vulnerable to acid and pepsin digestion, leading to erosion and ulcer formation within days to weeks of regular use.

Why It Matters

NSAID-induced ulcers have substantial clinical and economic impacts, causing approximately 100,000 hospitalizations and 16,500 deaths annually in the United States alone. These complications cost the healthcare system over $2 billion yearly in direct medical expenses. The risk is particularly concerning for elderly patients, who represent 60-70% of NSAID prescriptions but have 4-5 times higher complication rates. Understanding this mechanism has driven development of safer alternatives like COX-2 selective inhibitors and combination therapies with proton pump inhibitors. It also informs clinical guidelines recommending the lowest effective dose for the shortest duration, especially for high-risk patients. This knowledge helps balance pain management benefits against gastrointestinal risks in millions of patients worldwide.